StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Insys Therapeutics (INSY) Granted FDA Fast Track Designation for Cannabidiol for Prader-Willi Syndrome
December 26, 2017 8:30 AM
INSYS Therapeutics, Inc. (NASDAQ: INSY), announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Hot Corp. News
Hot FDA News
Next Articles
FDA Grants INSYS Therapeutics ‘Fast Track’ Designation for Cannabidiol (CBD) Oral Solution as Investigational Treatment for Prader-Willi Syndrome
December 26, 2017 8:30 AM